MedPath

Assessment of Circulatory Compromise With Ox-Imager Using a Vascular Occlusion Test Protocol

Not Applicable
Conditions
Circulatory; Change
Interventions
Device: The Ox-Imager Mini (Desaturation)
Registration Number
NCT03563105
Lead Sponsor
Modulated Imaging Inc.
Brief Summary

The objective of this study is to evaluate the performance of Modulated Imaging Inc.'s (MI) next generation Spatial Frequency Domain Imaging (SFDI) system to measure potential circulatory compromise.

Detailed Description

The objective of this study is to demonstrate the performance of Modulated Imaging Inc.'s (MI) next generation Spatial Frequency Domain Imaging (SFDI) system, "The Ox-Imager Mini". Potential circulatory compromise will be imaged in healthy volunteers using both the subject and predicate devices (Ox-Imager CS) in a Vascular Occlusion Test (VOT) model. The VOT model is an established paradigm to introduce transient ischemia in skin and the the subjects will be imaged during this time. The primary endpoint will be to measure significant decrease in tissue oxygen saturation after occlusion for both predicate and subject devices.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Over 18 years of age
Exclusion Criteria
  • History of congestive heart failure
  • Patients with existing wound or ulcer.
  • Rheumatoid arthritis
  • Pregnant or lactating women

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
DesaturationThe Ox-Imager Mini (Desaturation)Vascular Occlusion Test
Primary Outcome Measures
NameTimeMethod
Significant decrease in StO2 during occlusionimmediate

significant decrease in StO2 during occlusion

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Orange County Wound and Hyperbaric

🇺🇸

Santa Ana, California, United States

© Copyright 2025. All Rights Reserved by MedPath